Wall Street Upgrades Two Biotech Stocks: STRO Price Target Tripled, ORIC Now a Buy
Wedbush lifts Sutro to $60 on STRO-004 hopes; ORIC upgraded on strong cancer data and big market potential.
Wedbush lifts Sutro to $60 on STRO-004 hopes; ORIC upgraded on strong cancer data and big market potential.
Dexcom gains Elliott stake; will add board members and restructure, betting on CGM growth; shares rose 6%.
Private equity giants Blackstone and CD&R are exploring a bid for Magnum Ice Cream, the owner of Ben & Jerry’s and Cornetto, viewing it as a major turnaround opportunity.
Bill Ackman’s Pershing Square just took a big new stake in Microsoft. He calls the valuation “highly compelling” despite a 15% stock drop this year, citing huge AI upside in Azure, M365, and OpenAI.
US Antimony reported a Q1 loss and weak sales, but raised cash and expects stronger growth later in 2026 as new projects start.
Gemini revenue jumped 42%, boosted by services and cards, secured $100M in Winklevoss funding, cut losses, and its stock surged on the news.